- Market Capitalization, $K 122,003
- Shares Outstanding, K 70,522
- Annual Sales, $ 0 K
- Annual Income, $ -27,400 K
- 60-Month Beta 1.69
- Price/Sales N/A
- Price/Cash Flow N/A
- Price/Book 12.90
|Period||Period Low||Period High||Performance|
| || |
+0.0800 (+4.85%)since 08/24/21
| || |
+0.2700 (+18.49%)since 06/24/21
| || |
+0.7500 (+76.53%)since 09/24/20
Dare Bioscience (DARE) starts a phase I/II study to evaluate DARE-VVA1 to treat moderate to severe vulvar and vaginal atrophy.
Investigational therapy for women who cannot, or should not, take supplemental estrogen
Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will present at the Virtual Global...
Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will deliver a company presentation...
The discussion, Women's Health Case Study: Optimizing Study Enrollment During the COVID-19 Pandemic, will review the DARE-BVFREE Phase 3 study that was successfully initiated and completed during 2020
Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today reported financial results for the quarter ended June 30, 2021 and provided a company update.
-- Six-month priority review granted for DARE-BV1 with PDUFA target action date set for December 7, 2021.
Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, August 12, 2021,...
Presentation will highlight the positive topline results from the DARE-BVFREE Phase 3 randomized, double-blinded, placebo-controlled clinical trial evaluating Dare's product candidate DARE-BV1 in women...
/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VERB, ERIC, DARE, WISH, and EVGO.
|3rd Resistance Point||1.8098|
|2nd Resistance Point||1.7899|
|1st Resistance Point||1.7599|
|1st Support Level||1.7100|
|2nd Support Level||1.6901|
|3rd Support Level||1.6601|